Major Crypto Shock Wave on July 1 🚨

Click here for today's best stocks to trade. - [Image](www.elitetrade.club) Good Morning! Hey, guys and gals. It's Chris from Elite Trade Club, here to give you the day's premarket trading news. Happy Monday! It's June 27th. Let's get ready to trade! Markets 📈 The S&P 500 rallied 3.1%, and the Nasdaq spiked 3.2% in a strong showing for US benchmarks on Friday. The Russell 2K also gained 3.2%, while the Dow added 2.7%. Today, S&P 500 futures are up 0.5% heading into the open. Sponsored [Major Crypto Shock Wave on July 1]( 🚨 A groundbreaking new $30 Trillion shock wave is taking the crypto world by storm. As early as Friday, July 1, a number of tiny cryptos could soar as high as 1,000%. This is your chance to turn a small investment of $50 into substantial wealth. But you need to act ASAP! So, Mark your calendars before it's too late. [Click here for full details.]( What to Watch Today 👀 Bear Market Rally Markets are edging higher in the wake of the Fed's most recent rate hike. Recent economic data has signaled the economy could be slowing, and investors believe the slowdown could provide some much-needed inflationary relief and potentially give the Fed reason so slow their aggressive rate-cutting schedule. International 🌍 Asia Hong Kong's Hang Seng Composite jumped 2.4% overnight, while Japan's Nikkei 225 gained 1.4%. Australia's ASX 200 rallied 1.9%. Europe Germany's DAX is currently up 0.9%, and the UK's FTSE 100 is showing a 0.7% gain. The Euro Stoxx 600 has added 0.7% on the session. Major Earnings 💰 - NIKE [NKE] ... PM - Dynagas LNG Partners [DLNG] ...PM - Trip.com Group Limited [TCOM] ... PM - Concentrix [CNXC] ... PM - Jefferies Financial Group [JEF] ... PM Economy 🏗 - Durable goods orders [May] ... 8:30a - Core capital goods orders [May] ... 8:30a - Pending home sales index [May] ... 10a Running Hot 🔥 Gainers - Evofem Biosciences [EVFM] >> +76.3% - Agile Thrpe [AGRX] >> +38.3% - Ebang Intl [EBON] >> +17.4% Decliners - Toughbuilt Industries [TBLT] >> (11.1%) - Borqs Tech [BRQS] >> (25.4%) - Versus Systems Inc [VS] >> (18.3%) Axsome Therapeutics [AXSM] - Last Close: $24.46 News of a major regulatory milestone is lifting shares of Axsome Therapeutics. Regulatory filings revealed the biopharma firm received proposed labeling for its AXS-05 product candidate from the US Food & Drug Administration on June 24th. The proposed labeling from the FDA with respect to AXS-05 as a treatment for major depressive disorder. The company says it's currently reviewing the proposed labeling, and it will reply to the FDA to secure a final labeling agreement soon. AXSM is up 48.7% on news of the regulatory update. Our Take: AXSM has come down a lot from its 52W highs, but this press release shows the stock could have some catalysts ahead of it. There could be value in this trade, but tread lightly because this stock has been volatile in the past. OncoSec Medical [REV] - Last Close: $0.7868 Shares of OncoSec are up big just a day after the company received some good publicity. The clinical-stage biotech company announced Friday morning that its recent publication in Molecular Cancer Research will be featured as the June 2022 "Editor's Pick." The piece, titled Intratumoral Electroporation of Plasmid Encoded IL-12 and Membrane-Anchored Anti-CD3 Increases Systemic Tumor Immunity, summarizes pre-clinical results from OncoSec's next-generation cancer treatment approach, IL-12 combined with a polyclonal T cell stimulator. OncoSec says the treatment is effective in creating an antitumor immune response in patients and reducing suppressive effects of T-reg cells. OncoSec's warm reception in the peer-reviewed scientific journal is driving shares higher in today's premarket. ONCS is up 47.4% on active trading volume. Our Take: I'm not a medical expert, but OncoSec's cancer treatment sounds promising, and it's getting attention from the right folks. This one could have long-term potential if you can get in at a good price point. Epizyme [EPZM] - Last Close: $0.9540 Epizyme is rallying on news of a buyout deal. Ipsen SA has agreed to acquire Epizyme in an all-cash deal valued at approximately $247 million. Under the terms of the deal, shareholders will receive $1.45 per share, representing a 52% premium over the stock's Friday closing price, plus one contingent value right per share. The primary focus of the acquisition is on Epizyme's lead medicine, Tazverik (tazemetostat), a chemotherapy-free EZH2 inhibitor, which was granted FDA Accelerated Approval in 2020. The deal is expected to close in the third quarter. Our Take: There's not a lot of upside left between EPZM's current price and its buyout bid. Acutus Medical Inc [AFIB] - Last Close: $0.5384 Acutus is surging today after a series of major business updates. This morning, the arrhythmia management company announced it had received FDA clearance for its expanded suite of "left-heart access products." Acutus will now commercially launch the AcQCross Qx sytem for use with its TruSeal and FXD delivery system for the Watchman LAAC Device, which enables surgeons to conduct specialized cardiac operations more efficiently. The expanded launch could be a boon for Acutus's revenue growth in the months ahead. Investors are taking the news as a plus. Shares of AFIB are up 100.6% on active trading volume. Our Take: This move seems a little overdone, but this stock could be worth watching for an entrance opportunity on the way back down That's it for today! Thanks for reading, and good luck out there! Best Regards, Chris -- Elite Trade Club P.S... Want alerts delivered straight to your cell every morning for free?* [Click Here Now]( to get our watchlists sent directly to your phone! *Standard message/carrier rates may apply. Legal Stuff: Stocks featured in this newsletter are for entertainment purposes only. You should not base any investment decisions on information contained in my newsletter. Stocks featured in this newsletter may be owned by owners/operators of this website which could impact our ability to remain unbiased. Please consult a financial advisor before making any trading decisions. I may earn a small commission from links placed inside of these emails. 1969 S. ALAFAYA TRAIL Orlando FL 32828 USA [Unsubscribe]( | [Change Subscriber Options](